The Role of Gut Bacteria in Affecting Brain Health and Its Relationship with Neurological Diseases
DOI:
https://doi.org/10.69980/ajpr.v28i5.453Abstract
Background: The gut-brain axis represents a bidirectional communication network between the gastrointestinal system and the central nervous system, with gut microbiota playing a pivotal role in influencing brain health. Emerging evidence links gut dysbiosis to neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and major depressive disorder. This study aimed to investigate the relationship between gut microbiota composition and neurological health by comparing individuals with neurological diseases to healthy controls.
Methods: A quantitative, observational, case-control design was employed, involving 200 participants (100 with neurological disorders and 100 healthy controls). Fecal samples were collected, and microbial DNA was sequenced using the Illumina MiSeq platform targeting the V3-V4 regions of the 16S rRNA gene. Microbial diversity and composition were analyzed using bioinformatics tools (QIIME2, SILVA database). Sociodemographic, lifestyle, and clinical data were collected via questionnaires and medical records. Statistical analyses included t-tests, chi-square tests, and multivariable regression.
Results: The neurological group showed significantly lower levels of beneficial bacteria (Bacteroides: 41% vs. 78%; Lactobacillus: 38% vs. 66%) and higher levels of potentially harmful genera (Clostridium: 71% vs. 40%; Escherichia: 64% vs. 33%) compared to controls. Neuropsychiatric symptoms were prevalent, with 35% exhibiting severe cognitive impairment and 44% severe mood disturbances. Lifestyle factors like sedentary behavior (62% vs. 36%) and high sugar intake (66% vs. 40%) were more common in the neurological group.
Conclusion: The study confirms a distinct gut microbiota profile in individuals with neurological diseases, supporting the role of gut dysbiosis in neurological dysfunction. These findings highlight the potential for microbiota-targeted interventions (e.g., probiotics, dietary modifications) as therapeutic strategies. Further research is needed to establish causal mechanisms and develop personalized approaches for improving brain health through gut microbiota modulation.
References
1. Colella, M., Charitos, I. A., Ballini, A., Cafiero, C., Topi, S., Palmirotta, R., & Santacroce, L. (2023). Microbiota revolution: How gut microbes regulate our lives. World journal of gastroenterology, 29(28), 4368–4383. https://doi.org/10.3748/wjg.v29.i28.4368
2. Ashique, S., Mohanto, S., Ahmed, M. G., Mishra, N., Garg, A., Chellappan, D. K., Omara, T., Iqbal, S., & Kahwa, I. (2024). Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon, 10(13), e34092. https://doi.org/10.1016/j.heliyon.2024.e34092
3. Chandrasekaran, P., Weiskirchen, S., & Weiskirchen, R. (2024). Effects of Probiotics on Gut Microbiota: An Overview. International journal of molecular sciences, 25(11), 6022. https://doi.org/10.3390/ijms25116022
4. Chen, Y., Xu, J., & Chen, Y. (2021). Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients, 13(6), 2099. https://doi.org/10.3390/nu13062099
5. Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022). Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders. Metabolites, 12(11), 1064. https://doi.org/10.3390/metabo12111064
6. Luczynski, P., McVey Neufeld, K. A., Oriach, C. S., Clarke, G., Dinan, T. G., & Cryan, J. F. (2016). Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. The international journal of neuropsychopharmacology, 19(8), pyw020. https://doi.org/10.1093/ijnp/pyw020
7. Zhang, X., Tang, B., & Guo, J. (2023). Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Translational neurodegeneration, 12(1), 59. https://doi.org/10.1186/s40035-023-00392-8
8. Zhou, P., Chen, C., Patil, S., & Dong, S. (2024). Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony. Frontiers in nutrition, 11, 1355542. https://doi.org/10.3389/fnut.2024.1355542
9. Puig-Castellví, F., Pacheco-Tapia, R., Deslande, M., Jia, M., Andrikopoulos, P., Chechi, K., Bonnefond, A., Froguel, P., & Dumas, M. (2023). Advances in the integration of metabolomics and metagenomics for human gut microbiome and their clinical applications. TrAC Trends in Analytical Chemistry, 167, 117248. https://doi.org/10.1016/j.trac.2023.117248
10. Fekete, M., Lehoczki, A., Major, D., Fazekas-Pongor, V., Csípő, T., Tarantini, S., Csizmadia, Z., & Varga, J. T. (2024). Exploring the Influence of Gut-Brain Axis Modulation on Cognitive Health: A Comprehensive Review of Prebiotics, Probiotics, and Symbiotics. Nutrients, 16(6), 789. https://doi.org/10.3390/nu16060789
11. Suganya, K., & Koo, B. S. (2020). Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. International journal of molecular sciences, 21(20), 7551. https://doi.org/10.3390/ijms21207551
12. Tiwari, P., Dwivedi, R., Bansal, M., Tripathi, M., & Dada, R. (2023). Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance. Journal of clinical medicine, 12(4), 1650. https://doi.org/10.3390/jcm12041650
13. Ullah, H., Arbab, S., Tian, Y., Liu, C. Q., Chen, Y., Qijie, L., Khan, M. I. U., Hassan, I. U., & Li, K. (2023). The gut microbiota-brain axis in neurological disorder. Frontiers in neuroscience, 17, 1225875. https://doi.org/10.3389/fnins.2023.1225875
14. Dash, S., Syed, Y. A., & Khan, M. R. (2022). Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. Frontiers in cell and developmental biology, 10, 880544. https://doi.org/10.3389/fcell.2022.880544
15. Cryan, J. F., O'Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2020). The gut microbiome in neurological disorders. The Lancet. Neurology, 19(2), 179–194. https://doi.org/10.1016/S1474-4422(19)30356-4
16. Chaudhry, T. S., Senapati, S. G., Gadam, S., Mannam, H. P. S. S., Voruganti, H. V., Abbasi, Z., Abhinav, T., Challa, A. B., Pallipamu, N., Bheemisetty, N., & Arunachalam, S. P. (2023). The Impact of Microbiota on the Gut-Brain Axis: Examining the Complex Interplay and Implications. Journal of clinical medicine, 12(16), 5231. https://doi.org/10.3390/jcm12165231
17. He, Y., Wang, K., Su, N., Yuan, C., Zhang, N., Hu, X., Fu, Y., & Zhao, F. (2024). Microbiota-gut-brain axis in health and neurological disease: Interactions between gut microbiota and the nervous system. Journal of cellular and molecular medicine, 28(18), e70099. https://doi.org/10.1111/jcmm.70099
18. Suganya, K., & Koo, B. S. (2020). Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. International journal of molecular sciences, 21(20), 7551. https://doi.org/10.3390/ijms21207551
19. Kim, G. H., & Shim, J. O. (2023). Gut microbiota affects brain development and behavior. Clinical and experimental pediatrics, 66(7), 274–280. https://doi.org/10.3345/cep.2021.01550
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
